New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
06:20 EDTDOXAmdocs upgraded to Outperform from Perform at Oppenheimer
Oppenheimer upgraded Amdocs with a $47 price target citing the company's solid Q1 results and slightly improved FY14 guidance. Opco says the stock tends to outperform in uncertain market conditions.
News For DOX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for DOX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use